Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajog.2009.03.022 Byline: Kari L. Ring (a), Jennifer L. Young (b), Neal E. Dunlap (c), Willie A. Andersen (b), Bernard F. Schneider (c) Keywords: cervical cancer; chemosensitization; extended-field radiation therapy; toxicity Abstract: This retrospective study evaluated the toxicity of extended-field radiation therapy (EFRT), whole pelvis radiotherapy, and concurrent chemotherapy in patients treated with IB2-IIIB cervical carcinoma. Author Affiliation: (a) Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA (b) Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Virginia Health System, Charlottesville, VA (c) Department of Radiation Oncology, University of Virginia Health System, Charlottesville, VA Article History: Received 16 October 2008; Revised 9 February 2009; Accepted 6 March 2009 Article Note: (footnote) Cite this article as: Ring KL, Young JL, Dunlap NE, et al. Extended-field radiation therapy with whole pelvis radiotherapy and cisplatin chemosensitization in the treatment of IB2-IIIB cervical carcinoma: a retrospective review. Am J Obstet Gynecol 2009;201:109.e1-6.